Pricing Log in Create free account
Friday 6 November 2026 Export GMED’s income statement to Excel — free account

Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.

Revenue
−0.69%
EPS
+19.3%
Free cash flow
+10.1%

Quarter to September 2026, against a year earlier

72.47 8.97 −11.01%
Market cap
$10.9B
P/E
19.5×
Fwd P/E
18.8×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Globus Medical, Inc. (GMED) EV/Sales

Alert me on EV/Sales

As of 5 November 2026, Globus Medical, Inc. (GMED) trades at a EV/Sales of 3.5×. Over the past ten years it has ranged from 2.9× (July 2025) to 8.9× (June 2021); the current reading is higher than 12% of that period. That is above the Medical Devices industry median of 2.7× and in line with the Healthcare sector median of 3.5×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2025 4.1× (7.29%)
FY2024 4.4× 17.66%
FY2023 3.8× (44.08%)
FY2022 6.8× (5.30%)
FY2021 7.1× (6.31%)
FY2020 7.6× 8.16%
FY2019 7.0× 28.80%
FY2018 5.5× (8.07%)
FY2017 5.9× 61.18%
FY2016 3.7× (14.02%)

Quarterly newest first

Period EV/Sales Change
Sep 2026 3.3× (5.54%)
Jun 2026 3.5× (9.35%)
Mar 2026 3.8× (6.90%)
Dec 2025 4.1× 39.63%
43 more quarters

Against its own ten years

Low 2.9× High 8.9×
Ten-year median 4.8×
Current reading's percentile 13

EV/Sales against peers

Company EV/Sales
SNN Smith & Nephew SNATS, Inc. compare 1.6×
BRKR Bruker Corporation compare 3.0×
PODD Insulet Corporation compare 3.5×
GMED Globus Medical, Inc. 3.5×
BIO Bio-Rad Laboratories, Inc. compare 3.7×
BIO.B Bio-Rad Laboratories, Inc. compare 3.8×
PEN Penumbra, Inc. compare 7.7×
TXG 10x Genomics compare 11.5×
GKOS Glaukos Corporation compare 18.8×
Medical Devices industry median 2.7×
Healthcare sector median 3.5×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on GMED